genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
GEN Edge
EY Firepower Report: Biopharma M&A Poised to Rebound in 2021
Gene Therapy
Shooting the Messenger: Locana Bio Writes a New Script for RNA…
News
Gene Therapy
Paralyzed Mice Walk Again after Treatment with Designer Cytokine
Drug Discovery
New Antimicrobial Streptomyces Species Discovered in Ancient Irish Soil
Cancer
Circadian Rhythm Target Identified for Prostate Cancer
News
Why Antihistamines Often Don’t Work to Control Severe Itch
Genetics
Potential Pathway for Rare Neurological Disorder Discovered
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
Bioprocessing
New Promise for Spinal-Cord Injuries
Drug Discovery
Trojan Horse Antidotes Designed to Neutralize Lethal Botulinum Toxin
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Gene Therapy
Paralyzed Mice Walk Again after Treatment with Designer Cytokine
Drug Discovery
New Antimicrobial Streptomyces Species Discovered in Ancient Irish Soil
Cancer
Circadian Rhythm Target Identified for Prostate Cancer
Bioprocessing
Major Expansions Planned for Cobra Biologics and Cognate BioServices
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Immunotherapies
Immunotherapies
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immunotherapies
Cancer Immunotherapy: Getting Better with a Little Help from Helper T Cells
Immunotherapies
BMS, Kyowa Hakko Kirin Launch Immuno-Oncology Collaboration
Immunotherapies
NIH Gives Genesis Biopharma Access to 43 Cancer Cell Therapy Patents for $1.2M
Immunotherapies
Aduro Licenses Cancer Immunotherapy from BioSante
Immunotherapies
Domain Swaps Lessen Autoimmunity in TCR Gene Therapy
Immunotherapies
Immunotherapy Triggers Release of Mitochondrial DNA and Trips Alarm
Immunotherapies
Immunotherapy Shows Promise for Myeloma
Immunotherapies
Immunotherapy Strategy for Advanced Skin Cancer Identified
Immunotherapies
Cancer Immunotherapy May be Improved by Targeting Ferroptosis
Immunotherapies
Plexxikon, Merck Partner on Combination Therapy Trial
Immunotherapies
Breast Cancer Recurrence Associated with Weak T Cell Response
Immunotherapies
Lilly, NextCure Launch Cancer Immunotherapy Partnership
Immunotherapies
Veloxis Restructures to Focus on Late-Stage Once-Daily Immunosuppressant
Immunotherapies
Apeiron Gains Rights to Phase III-Stage Neuroblastoma Treatment
eBooks
Engineering the Immune Response for Therapeutic Success
1
2
3
...
53
Page 1 of 53
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Mouse-Human chimeric mAb targeting GD2 was developed by CCRI and SIOPEN.[© Francois du Plessis - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/June22_2011_346419_BabyInHospital_ApeironNeuroblastoma2282551982-324x160.jpg "Apeiron Gains Rights to Phase III-Stage Neuroblastoma Treatment")
